CORONA REMEDIES
Back to Balance Sheet
|
CORONA REMEDIES Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Capital Work in Progress | ₹143 Cr | ₹186 Cr | ₹121 Cr | ₹65 Cr |
What is the latest Capital Work in Progress ratio of CORONA REMEDIES ?
| Year | Capital Work in Progress |
|---|---|
| Mar2026 | ₹143 Cr |
| Mar2025 | ₹186 Cr |
| Mar2024 | ₹121 Cr |
| Mar2023 | ₹65 Cr |
How is Capital Work in Progress of CORONA REMEDIES Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2026 | ₹143 Cr | -23.03 | |
| Mar2025 | ₹186 Cr | 54.20 | |
| Mar2024 | ₹121 Cr | 86.35 | |
| Mar2023 | ₹65 Cr | - | |
Compare Capital Work in Progress of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹12,464.6 Cr | -0.8% | -0.7% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,562.0 Cr | -3.2% | -7.8% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,572.0 Cr | -3.3% | -0.2% | 63.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,871.0 Cr | -2.4% | -5% | 33.6% | Stock Analytics | |
| CIPLA | ₹107,770.0 Cr | -4% | -5.6% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,829.0 Cr | -1.2% | 4.1% | -4.2% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | -0.8% |
-0.7% |
|
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses